Compare

Mutares SE & Co. KGaA/€MUX

1D1W1M3M6MYTD1Y5YMAX

About Mutares SE & Co. KGaA

Mutares SE & Co. KGaA is a Germany-based private equity firm focused on acquiring and operationally transforming medium-sized companies in turnaround situations. The company's core business involves investments in struggling companies, with the aim of restructuring them to create value. Mutares operates across several segments, including Automotive & Mobility, Engineering & Technology, and Goods & Services, offering governance and strategic support to its portfolio companies. Founded in 2008 and headquartered in Munich, Germany, Mutares leverages its industry expertise and restructuring experience to improve the operational efficiency and profitability of its acquisitions. The firm is noted for its hands-on approach to managing transitions and is active primarily in European markets.
Ticker
€MUX
Sector
Finance
Primary listing
XETRA
Employees
35,000
Headquarters
Munich, Germany

MUX Metrics

BasicAdvanced
€671M
-
-€8.85
0.64
€2.00
7.60%

What the Analysts think about MUX

Analyst ratings (Buy, Hold, Sell) for Mutares SE & Co. KGaA stock.
Analyst projections of the future price of Mutares SE & Co. KGaA stock.

Bulls say / Bears say

Group revenue rose 9% to €3.4bn in the first half of 2026, while adjusted EBITDA swung to €66.7m from a loss of €88.5m a year earlier. That points to a meaningful operational recovery, and management maintained its 2026 guidance. (Mutares)
Recent exits show the turnaround model can deliver: Mutares says it earned about €50m in gross proceeds from Terranor at a return on invested capital above its target range, and completed the sale of NEM Energy after making it a profitable standalone business. These sales also bring cash back to the holding company. (Mutares, EQS News)
The completed acquisition of SABIC’s engineering thermoplastics business adds a business with about €2bn in annual revenue and expands Mutares into a new Chemicals & Materials segment. Mutares has confirmed 2026 group revenue guidance of €7.9bn to €9.1bn. (Mutares)
The portfolio remains uneven: Mutares identified significant challenges at Lapeyre, Prénatal, Stuart, La Rochette and Natura, while recent acquisitions reduced first-half adjusted EBITDA by €17.1m. A continued drag at these businesses could delay the expected improvement. (Mutares)
Financing remains a key risk: Mutares reported that a bond covenant was breached at the end of 2025 and disclosed a liquidity and refinancing risk that could threaten its ability to continue as a going concern. About €222m of its 2023/2027 bond remains outstanding ahead of a planned Q4 2026 refinancing, with maturity in March 2027. (Mutares, Mutares)
The April 2026 share issue added 4.27m shares, roughly a 20% increase on the pre-issue count, diluting existing holders. Around 80% of the €105m proceeds is earmarked for expansion, so the investment case depends in part on new deals earning an adequate return. (Mutares)
Data summarised monthly by Lightyear AI. Last updated on 26 Oct 2026.

MUX Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

MUX Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.